dipyridamole has been researched along with Myocardial Bridging in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Myocardial Bridging: A malformation that is characterized by a muscle bridge over a segment of the CORONARY ARTERIES. Systolic contractions of the muscle bridge can lead to narrowing of coronary artery; coronary compression; MYOCARDIAL ISCHEMIA; MYOCARDIAL INFARCTION; and SUDDEN CARDIAC DEATH.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Siniscalchi, C | 1 |
Basaglia, M | 1 |
Gaibazzi, N | 1 |
Hsieh, PJ | 1 |
Su, HY | 1 |
Lo, HS | 1 |
Chen, ML | 1 |
2 other studies available for dipyridamole and Myocardial Bridging
Article | Year |
---|---|
Break into left anterior descending coronary artery suggest myocardial bridging.
Topics: Aged; Coronary Vessels; Dipyridamole; Echocardiography; Electrocardiography; Female; Humans; Myocard | 2016 |
Dipyridamole 201Tl myocardial SPECT in the assessment of a patient with myocardial bridging and concomitant atherosclerotic coronary artery disease.
Topics: Coronary Artery Disease; Dipyridamole; Heart; Humans; Male; Middle Aged; Myocardial Bridging; Thalli | 2012 |